Huang Y-C, Yeh M-K, Cheng S-N, Chiang C-H
Graduate Institute of Life Sciences, National Defense Medical Center, University of National Defense, Taipei, Taiwan.
J Microencapsul. 2003 Jul-Aug;20(4):459-72. doi: 10.1080/0265204021000058456.
Betamethasone (BTM)-loaded microparticles prepared by a spray drying method using chitosan (CTS) as raw material, type-A gelatin and ethylene oxide-propylene oxide block copolymer (Pluronic F68) as modifiers. The BTM-loaded in varied chitosan/Pluronic F68/gelatin microparticle formulations was investigated. By properly choosing excipient type and concentration a high degree of control was achieved over the physical properties of the BTM-loaded microparticles. Microparticle characteristics (zeta potential, tap density, particle size and yield), loading efficiencies, microparticle morphology and in-vitro release properties were examined. Surface morphological characteristics and surface charges of prepared microparticles were observed by using scanning electron microscopy (SEM) and microelectrophoresis. A SEM micrograph shows that the particle sizes of the varied chitosan composed microparticles ranged from 1.1-4.7 microm and the external surfaces appear smooth. The BTM-loaded microparticles entrapped in the chitosan/Pluronic F68/gelatin microparticles with trapping efficiencies up to 93%, collected yield rate 44%, and mean particle size varied between 1-3 microm, positive surface charge (20-40 mv), and tap densities (0.04-0.40 g/cm3) were obtained. The collected BTM yield and size of particle was increased with increasing BTM-loaded amount but both zeta potential and tap density of the particles decreased with increasing BTM-loaded amount. The in vitro release of BTM showed a dose-dependent burst followed by a slower release phase that was proportional to the drug concentration in the concentration range between 5-30%w/w. The in vitro drug release from the chitosan/Pluronic F68/gelatin 1/0.1/0.4 microspheres had a prolong release pattern. These formulation factors were correlated to particulate characteristics for optimizing BTM microspheres in pulmonary delivery.
以壳聚糖(CTS)为原料、A型明胶和环氧乙烷 - 环氧丙烷嵌段共聚物(泊洛沙姆F68)为改性剂,通过喷雾干燥法制备了载倍他米松(BTM)的微粒。研究了不同壳聚糖/泊洛沙姆F68/明胶微粒制剂中载有的BTM。通过适当选择辅料类型和浓度,对载BTM微粒的物理性质实现了高度控制。考察了微粒特性(ζ电位、堆密度、粒径和产率)、载药效率、微粒形态和体外释放特性。使用扫描电子显微镜(SEM)和微电泳观察制备微粒的表面形态特征和表面电荷。SEM显微照片显示,不同壳聚糖组成的微粒粒径范围为1.1 - 4.7微米,外表面看起来光滑。载于壳聚糖/泊洛沙姆F68/明胶微粒中的载BTM微粒,包封率高达93%,收集产率为44%,平均粒径在1 - 3微米之间,表面带正电荷(20 - 40毫伏),堆密度为(0.04 - 0.40克/立方厘米)。随着BTM载量增加,收集到的BTM产率和粒径增大,但微粒的ζ电位和堆密度均降低。BTM的体外释放呈现剂量依赖性的突释,随后是较慢的释放阶段,在5 - 30%w/w的浓度范围内与药物浓度成正比。壳聚糖/泊洛沙姆F68/明胶1/0.1/0.4微球的体外药物释放具有缓释模式。这些制剂因素与微粒特性相关,以优化BTM微球在肺部给药中的应用。